Arrowhead Subsidiary Signs Agreement to Integrate Its Products into Major Display Manufacturer’s Flat Panel Displays

Arrowhead Research announced today that its majority owned subsidiary, Unidym, has entered an agreement with a major liquid crystal display (LCD) manufacturer to integrate carbon nanotube-based products into display applications.

"The market for flat panel displays is over eighty billion dollars annually, and we are now working with one of the world’s leaders," remarked Art Swift, CEO of Unidym. "We expect our products to reduce manufacturing costs and improve image quality in flat panel displays."

Under the terms of the agreement, Unidym will work with the customer to integrate its products into the customer’s manufacturing process. Upon conclusion of the development effort, the parties intend to enter a commercial relationship.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Arrowhead Pharmaceutical. (2019, March 19). Arrowhead Subsidiary Signs Agreement to Integrate Its Products into Major Display Manufacturer’s Flat Panel Displays. AZoNano. Retrieved on April 18, 2024 from https://www.azonano.com/news.aspx?newsID=4591.

  • MLA

    Arrowhead Pharmaceutical. "Arrowhead Subsidiary Signs Agreement to Integrate Its Products into Major Display Manufacturer’s Flat Panel Displays". AZoNano. 18 April 2024. <https://www.azonano.com/news.aspx?newsID=4591>.

  • Chicago

    Arrowhead Pharmaceutical. "Arrowhead Subsidiary Signs Agreement to Integrate Its Products into Major Display Manufacturer’s Flat Panel Displays". AZoNano. https://www.azonano.com/news.aspx?newsID=4591. (accessed April 18, 2024).

  • Harvard

    Arrowhead Pharmaceutical. 2019. Arrowhead Subsidiary Signs Agreement to Integrate Its Products into Major Display Manufacturer’s Flat Panel Displays. AZoNano, viewed 18 April 2024, https://www.azonano.com/news.aspx?newsID=4591.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.